Hypertension and antiangiogenesis: the Janus face of VEGF inhibitors

Touyz, R. M. and Lang, N. N. (2019) Hypertension and antiangiogenesis: the Janus face of VEGF inhibitors. JACC: CardioOncology, 1(1), pp. 37-40. (doi: 10.1016/j.jaccao.2019.08.010)

[img] Text
239358.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

177kB

Abstract

No abstract available.

Item Type:Articles (Editorial)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Lang, Professor Ninian and Touyz, Professor Rhian
Authors: Touyz, R. M., and Lang, N. N.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:JACC: CardioOncology
Publisher:Elsevier
ISSN:2666-0873
ISSN (Online):2666-0873
Published Online:24 September 2019
Copyright Holders:Copyright © 2019 The Authors
First Published:First published in JACC: CardioOncology 1(1): 37-40
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
190615Vascular Noxs as therapeutic targets and biomarkers in hypertensionRhian TouyzBritish Heart Foundation (BHF)CH/12/4/29762Institute of Cardiovascular & Medical Sciences